The 2009 World Health Organization report on global health risks identifies hypertension,
smoking, raised glucose, physical inactivity, obesity and dyslipidaemia, in that order, as …

Objectives: The study sought to explore sex-related differences in coronary atheroma
regression following high-intensity statin therapy. Background: Guidelines now recommend …

Background—Despite the known benefit of intensive statin therapy for reducing future
cardiovascular events, its effectiveness in women has been questioned by some. Methods …

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality
worldwide,[1] and therefore strategies that aim to improve prevention in people without …

In their editorial Byrne and Wild grapple with the “paradox that arises” when statins, targeted
to lower cardiovascular risk, increase diabetes, one of the most potent cardiovascular risk …

To the Editor: Fitchett et al have presented supporting evidence for the 'lower LDL-C is
better'concept. Much of the proposed benefit is in events, however defined, and that may …

Objective We examined lipid profile, lipid-lowering therapy, side effects of statins, treatment
effectiveness and its associated factors in women with FH and compared the parameters …

Background—Despite the known benefit of intensive statin therapy for reducing future
cardiovascular events, its effectiveness in women has been questioned by some. Methods …

Objective: This study aimed to investigate the effects of C-reactive protein (CRP) or placenta
growth factor (PIGF) on atherosclerotic plaque stability. Methods: Fifty-five patients were …

To the Editor: Fitchett et al have presented supporting evidence for the 'lower LDL-C is
better'concept. Much of the proposed benefit is in events, however defined, and that may …